Benzinga's Top #PreMarket Gainers
Acura Pharmaceuticals (NASDAQ: ACUR) soared 17.86% to $1.98 in the pre-market trading as the company announced results of meeting with the FDA.
Gilead Sciences (NASDAQ: GILD) shares jumped 3.39% to $76.50 in pre-market trading after the company reported positive data from interim Phase 2 results for GS-9973 in previously treated chronic lymphocytic leukemia.
Celgene (NASDAQ: CELG) shares gained 2.15% to $170.00 in the pre-market. Cantor lifted its price target on the stock from $171 to $186.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.